Skip to main content
See every side of every news story
Published loading...Updated

Pep2Tango Therapeutics Receives Investment from Versant Ventures

Summary by Citybiz
Pep2Tango Therapeutics, a Potomac, MD-based startup focused on weight loss therapies, received an investment from Versant Ventures. The amount of the deal was not disclosed. The company intends to use the funds to develop its novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. Led by President, CEO and Chairperson Cristina Rondinone, Ph.D., and CSO Soumitra Ghosh, Ph.D., Pep2Tango Therapeutics is a biotech…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

FinSMEs broke the news on Friday, November 22, 2024.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal